Life Sciences

US Presidential hopefuls set their sights on pharma patents

With several leading Democratic candidates threatening to circumvent pharma IP, next year’s election could prove pivotal for right owners

US Presidential hopefuls set their sights on pharma patents
19 Nov 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

14 Nov 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

Latest

View all
18 Nov 2019

South Africa's top court issues first patent decision but fails to clarify infringement defence uncertainties

The country’s Constitutional Court, which split down the middle, refused to grant an appeal to challenge a Merck patent on new grounds Read more

13 Nov 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options Read more

12 Nov 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016 Read more

8 Nov 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019 Read more

News

View all
8 Nov 2019

A snapshot of the global patent landscape in eight charts  

A recently issued WIPO report based on multiple data points sheds light on the state of play in worldwide patenting activity Read more

6 Nov 2019

New report reveals why SMEs want patents and the opportunities they bring

Study released by the European Patent Office sheds light on the growing sophistication of smaller businesses seeking protection for their inventions Read more

2 Nov 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators Read more

31 Oct 2019

IAM honours Asia’s IP leaders

The winners of our annual Asia IP Elite awards for the teams, deal and individual of the year were revealed before a sold-out crowd at IPBC Asia 2019 Read more

Analysis

View all
7 Nov 2019

Multi-billion dollar IP dispute exposes dangers of life sciences collaborations

Seattle Genetics is demanding rights to Daiichi Sankyo’s potential blockbuster cancer treatment, which it says is an improvement on the proprietary technology included in their previous partnership Read more

6 Nov 2019

Chinese patents surviving validity challenges in greater numbers

Invention patents had a coin flip chance of full invalidation by CNIPA over the past decade, but the past three years show a higher survival rate Read more

5 Nov 2019

Top tips for patenting personalised medicine 

As medical treatments become increasingly bespoke, we reveal some best practices to help inventors secure the highest quality patents possible. Read more

5 Nov 2019

Monsanto prevails in key $7.7 billion Brazilian licensing lawsuit

In a big win for patent owners, the first-of-its-kind ruling upholds biotech innovators’ rights to collect royalties on saved GM seeds Read more

Insights

View all
24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more

1 Apr 2019

IP market news highlights

The big stories from the IAM platform in February and March. Read more